Kiniksa Pharmaceuticals(KNSA.US)

Last Updated 19:00:00 ET
longbridge loading

Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Strong Q1 Results And Raised Revenue Guidance

Simplywall·
US
KNSA
-0.56%
Simplywall·
US
KNSA
-0.56%

Kornitzer Capital Management Inc. KS Purchases New Shares in Kiniksa Pharmaceuticals International, plc $KNSA

Market Beat·
US
KNSA
-0.56%
Market Beat·
US
KNSA
-0.56%

Kiniksa Pharmaceuticals CSO Resigns and Shifts to Advisor

Tip Ranks·
US
KNSA
-0.56%
Tip Ranks·
US
KNSA
-0.56%

Kiniksa Pharmaceuticals’ Mine Safety Disclosure: No Incidents Reported but Transparency Gaps Remain for Investors

Tip Ranks·
US
KNSA
-0.56%
Tip Ranks·
US
KNSA
-0.56%

Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today

nasdaq·
US
KNSA
-0.56%
nasdaq·
US
KNSA
-0.56%

Top 10 US Stock Gainers (4.28)

Top Gainers&Losers·
US
KFRC
-0.59%
US
KNSA
-0.56%
US
OMCL
+1.39%
Top Gainers&Losers·
US
KFRC
-0.59%
US
KNSA
-0.56%
US
OMCL
+1.39%

Morning News Wrap-Up, 4/28/26: Today's Biggest Stock Market Stories!

Tip Ranks·
US
NEXR
-2.19%
US
KNSA
-0.56%
US
DPZ
+1.54%
Tip Ranks·
US
NEXR
-2.19%
US
KNSA
-0.56%
US
DPZ
+1.54%

Lorusso Lifts Price Target to $65 and Reiterates Buy on Strong Arcalyst Momentum and Upside Potential

Tip Ranks·
US
KNSA
-0.56%
Tip Ranks·
US
KNSA
-0.56%

Crane shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY2026 Adjusted EPS guidance.

benzinga_article·
US
CR
-1.98%
benzinga_article·
US
CR
-1.98%
© 2026 Longbridge｜Disclaimer